Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

I previously recommended NAC in June, anticipating a muni sector rebound, which has proven accurate. Going forward, I think gains will be more modest. The fund offers value for investors seeking ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Data supplied by Morningstar and accurate on Jul 31, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...